Effects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heart

Acta Pharmacologica Sinica

Volumn 26, Issue 6, 2005, Pages 696-704

  Zheng, Xia ^a   Hu, Shen Jiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ca2+ transporting ATPase; Calcium regulatory protein; Endoplasmic reticulum; Myocardial contraction; Reverse transcriptase polymerase chain reaction; Ryanodine receptor calcium release channel; Simvastatin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; MESSENGER RNA; PHOSPHOLAMBAN; REGULATOR PROTEIN; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM ADENOSINE TRIPHOSPHATASE; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART PERFORMANCE; MALE; MTT ASSAY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIMVASTATIN; VENTRICULAR PRESSURE;

EID: 20444387975     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00105.x     Document Type: Article

References (26)

1. The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. 2+ mobilization in vascular smooth muscle cells. J Cardiovasc Pharmacol 1996; 27: 383-91.
4. 2+ signaling in endothelial cells: involvement of Rho protein. Biochem Biophys Res Commun 2001; 280: 486-90.
5. 2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors. Biochem Biophys Res Commun 1994; 202: 1579-8.
6. 2+ exchanger. FEBS Lett 1994; 343: 151-4.
7. 2+ release and vascular reactivity. J Cardiovasc Pharmacol 1999; 34: 95-101.
8. 2+ homeostasis. Eur J Pharmacol 2001; 415: 217-24.
9. Yokoyama K, Ishibashi T, Ohkawara H, Kimura J, Matsuoka I, Sakamoto T. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 2002; 105: 962-7.
10. Hill BJ, Dixon JL, Sturek M. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet . Atherosclerosis 2001; 159: 117-24.
11. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition. Atherosclerosis 1999; 144: 335-42.
12. Kurosaki K, Ikeda U, Maeda Y, Shimpo M, Ueno S, Shimada K. Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes. Cardiovasc Res 1998; 38: 192-7.
13. Zhong Y, Ahmed S, Grupp IL, Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 2001; 281: H1137-47.
14. Kwak BR, van Kempen MJ, Theveniau-Ruissy M, Gros DB, Jongsma HJ. Connexin expression in cultured neonatal rat myocytes reflects the pattern of the intact ventricle. Cardiovasc Res 1999; 44: 370-80.
15. Huang YT, Chueh SC, Teng CM, Guh JH. Investigation of oua-bain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells. Biochem Pharmacol 2004; 67: 727-33.
16. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG) CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998; 95: 8880-5.
17. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 1999; 100: 178-84.
18. Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000; 20: 61-9.
19. Bourcier T, Libby P. HMG-CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 556-62.
20. Di Napoli P, Antonio Taccardi A, Grilli A, Spina R, Felaco M, Barsotti A. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res 2001; 51: 283-93.
21. Jones SP, Trocha SD, Lefer DJ. Pretreatment with Simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion. Arterioscler Thromb Vasc Biol 2001; 21: 2059-64.
22. Wassmann S, Laufs U, Baumer AT, Muller K, Ahlbory K, Linz W. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001; 37: 1450-7.
23. Satoh K, Ichihara K. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischemic rat hearts. Eur J Pharmacol 1995; 292: 271-5.
24. Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res 1991; 69: 266-76.
25. Kong JY, Rabkin SW. Mitochondrial effects with ceramide-induced cardiac apoptosis are different from those of palmitate. Arch Biochem Biophys 2003; 412: 196-206.
26. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 1994; 269: 27580-8.